Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02146885 · ClinicalTrials.gov registry record
The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 21
- Enrollment target
NCT02146885 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 21 participants.
The verdict
NCT02146885 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The first step in any clinical intervention against obesity involves sustained lifestyle changes. Researcher can use these strategies to beneficial the effects of weight and on cardiovascular risk. The researcher develope methods for assessing the effectiveness use optical technology to make such assessments, specifically in the area of fatty tissue can predict the effectiveness of the intervention in causing weight reduction and treating metabolic disease.
Interventions
- OTHER Weight Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-01-08 |
| Est. Completion | 2017-01-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02146885
The ClinicalTrials.gov registry entry for NCT02146885 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Weight Control is the first listed.
NCT02146885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02146885 about?
NCT02146885 is a clinical study titled "The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention". The first step in any clinical intervention against obesity involves sustained lifestyle changes. Researcher can use these strategies to beneficial the effects of weight and on cardiovascular risk. The researcher develope methods for assessing the effectiveness use optical technology to make such as...
What is the current status of trial NCT02146885?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2013-01-08. Estimated completion is 2017-01-13.
What interventions are being tested in trial NCT02146885?
The interventions under investigation include: Weight Control (OTHER).
Who is sponsoring clinical trial NCT02146885?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.